Meeting
2021 ASCO Annual Meeting
Performance of a targeted methylation-based multi-cancer early detection test by race/ethnicity.
Authors
Wai Hong Wilson Tang
Cleveland Clinic, Cleveland, OH
Wai Hong Wilson Tang , Habte Aragaw Yimer , Mohan K. Tummala , Spencer Shao , Gina G. Chung , Jessica M. Clement , Jingjing Gao , Earl Hubbell , Kathryn Kurtzman , Charles Swanton , Lewis R. Roberts
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
New Targets and New Technologies (non-IO)
Clinical Trial Registration Number
NCT02889978
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3071)
DOI
10.1200/JCO.2021.39.15_suppl.3071
Abstract #
3071
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Detection of cancer signal for over 50 AJCC cancer types with a multi-cancer early-detection test.
First Author: Habte Aragaw Yimer
Poster
2023 ASCO Annual Meeting
Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms.
First Author: Giuseppe Di Caro
Poster
2019 ASCO Annual Meeting
Genome-wide cell-free DNA (cfDNA) methylation signatures and effect on tissue of origin (TOO) performance.
First Author: Minetta C. Liu
Poster
2019 ASCO Annual Meeting
The Circulating Cell-free Genome Atlas (CCGA) Study: Follow-up (F/U) on non-cancer participants with cancer-like cell-free DNA signals.
First Author: Allen Lee Cohn